NCT05718024View on ClinicalTrials.gov

Night-time Dexmedetomidine-esketamine Infusion and Sleep Quality With Mechanical Ventilation

PHASE4CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

April 22, 2025

Study Completion Date

May 23, 2025

Conditions
Intensive Care UnitMechanical VentilationDexmedetomidineEsketamineSleep Quality
Interventions
DRUG

Dexmedetomidine-esketamine

Dexmedetomidine-esketamine combination will be infused during night-time (8 pm to 6:30 am) for ICU patients with mechanical ventilation.

DRUG

Propofol-remifentanil

Propofol and remifentanil will be infused during night-time (8 pm to 6:30 am) for ICU patients with mechanical ventilation.

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT05718024 - Night-time Dexmedetomidine-esketamine Infusion and Sleep Quality With Mechanical Ventilation | Biotech Hunter | Biotech Hunter